Skip to main content
    A

    Alpha Tau Medical Ltd (DRTS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $11.97
    -1.41 (-10.54%)

    Market Cap: $1.24B

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Alpha Tau Medical Ltd (DRTS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Alpha Tau Medical (DRTS) to earn -$0.96 per share in the fiscal year ending Dec 31, 2026, on revenue of $755000. Of 5 analysts, 4 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 4 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 80% of the ratings.

    RatingAnalystsShare
    Strong Buy120.0%
    Buy360.0%
    Hold120.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    5

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 1794.0%.

    Fiscal year ending Dec 31, 2026
    -$0.96
    EPS consensus, revenue $755000
    Fiscal year ending Dec 31, 2027
    -$0.54
    EPS consensus, revenue $14.30M
    Next report
    Nov 24, 2026
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.96-$1.08 to -$0.555$755000N/A2
    Dec 31, 2027-$0.54-$0.60 to -$0.505$14.30MN/A3

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.16-$0.17 to -$0.166$629003N/A5

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 2 upward and 7 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202614
    Fiscal year ending Dec 31, 202713

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.88.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.96-$0.96-$0.96-$0.96-$0.88N/A
    Fiscal year ending Dec 31, 2027-$0.54-$0.53-$0.53-$0.53-$0.53N/A

    Frequently Asked Questions About DRTS

    What is the DRTS stock forecast?

    Consensus analyst estimates put Alpha Tau Medical's EPS at -$0.96 for the fiscal year ending Dec 31, 2026, on revenue of $755000. The consensus rating from 5 analysts is Buy.

    How do analysts rate DRTS stock?

    Of 5 analysts covering Alpha Tau Medical, 1 rates it Strong Buy, 3 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from DRTS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.96, with estimates from -$1.08 to -$0.55 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.54, with estimates from -$0.60 to -$0.50 from 5 analysts.

    What revenue do analysts expect from Alpha Tau Medical next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $755000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $14.30M.

    How many analysts cover DRTS?

    5 analysts rate Alpha Tau Medical stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.